339 related articles for article (PubMed ID: 16287979)
1. Toll-like receptor 3 ligand attenuates LPS-induced liver injury by down-regulation of toll-like receptor 4 expression on macrophages.
Jiang W; Sun R; Wei H; Tian Z
Proc Natl Acad Sci U S A; 2005 Nov; 102(47):17077-82. PubMed ID: 16287979
[TBL] [Abstract][Full Text] [Related]
2. Sesamin ameliorates lipopolysaccharide/d-galactosamine-induced fulminant hepatic failure by suppression of Toll-like receptor 4 signaling in mice.
Ma L; Gong X; Kuang G; Jiang R; Chen R; Wan J
Biochem Biophys Res Commun; 2015 May; 461(2):230-6. PubMed ID: 25866179
[TBL] [Abstract][Full Text] [Related]
3. Salvage effect of E5564, Toll-like receptor 4 antagonist on d-galactosamine and lipopolysaccharide-induced acute liver failure in rats.
Kitazawa T; Tsujimoto T; Kawaratani H; Fukui H
J Gastroenterol Hepatol; 2010 May; 25(5):1009-12. PubMed ID: 20546456
[TBL] [Abstract][Full Text] [Related]
4. Reduced hepatic injury in Toll-like receptor 4-deficient mice following D-galactosamine/lipopolysaccharide-induced fulminant hepatic failure.
Ben Ari Z; Avlas O; Pappo O; Zilbermints V; Cheporko Y; Bachmetov L; Zemel R; Shainberg A; Sharon E; Grief F; Hochhauser E
Cell Physiol Biochem; 2012; 29(1-2):41-50. PubMed ID: 22415073
[TBL] [Abstract][Full Text] [Related]
5. Emodin ameliorated lipopolysaccharide-induced fulminant hepatic failure by blockade of TLR4/MD2 complex expression in D-galactosamine-sensitized mice.
Yin X; Gong X; Jiang R; Kuang G; Wang B; Zhang L; Xu G; Wan J
Int Immunopharmacol; 2014 Nov; 23(1):66-72. PubMed ID: 25173984
[TBL] [Abstract][Full Text] [Related]
6. Glycine attenuates endotoxin-induced liver injury by downregulating TLR4 signaling in Kupffer cells.
Xu FL; You HB; Li XH; Chen XF; Liu ZJ; Gong JP
Am J Surg; 2008 Jul; 196(1):139-48. PubMed ID: 18565339
[TBL] [Abstract][Full Text] [Related]
7. Pretreatment of lipopolysaccharide (LPS) ameliorates D-GalN/LPS induced acute liver failure through TLR4 signaling pathway.
Zhang S; Yang N; Ni S; Li W; Xu L; Dong P; Lu M
Int J Clin Exp Pathol; 2014; 7(10):6626-34. PubMed ID: 25400741
[TBL] [Abstract][Full Text] [Related]
8. Dysregulated Toll-like receptor expression and signaling in bone marrow-derived macrophages at the onset of diabetes in the non-obese diabetic mouse.
Mohammad MK; Morran M; Slotterbeck B; Leaman DW; Sun Y; Grafenstein Hv; Hong SC; McInerney MF
Int Immunol; 2006 Jul; 18(7):1101-13. PubMed ID: 16728431
[TBL] [Abstract][Full Text] [Related]
9. Toll-like receptor stimulation induces airway hyper-responsiveness to bradykinin, an effect mediated by JNK and NF-kappa B signaling pathways.
Bachar O; Adner M; Uddman R; Cardell LO
Eur J Immunol; 2004 Apr; 34(4):1196-207. PubMed ID: 15048731
[TBL] [Abstract][Full Text] [Related]
10. Protein kinase C-eta and phospholipase D2 pathway regulates foam cell formation via regulator of G protein signaling 2.
Lee HK; Yeo S; Kim JS; Lee JG; Bae YS; Lee C; Baek SH
Mol Pharmacol; 2010 Sep; 78(3):478-85. PubMed ID: 20558593
[TBL] [Abstract][Full Text] [Related]
11. Scoparone attenuates D-galactosamine/lipopolysaccharide-induced fulminant hepatic failure through inhibition of toll-like receptor 4 signaling in mice.
Kang JW; Kim DW; Choi JS; Kim YS; Lee SM
Food Chem Toxicol; 2013 Jul; 57():132-9. PubMed ID: 23535186
[TBL] [Abstract][Full Text] [Related]
12. Role of adaptor TRIF in the MyD88-independent toll-like receptor signaling pathway.
Yamamoto M; Sato S; Hemmi H; Hoshino K; Kaisho T; Sanjo H; Takeuchi O; Sugiyama M; Okabe M; Takeda K; Akira S
Science; 2003 Aug; 301(5633):640-3. PubMed ID: 12855817
[TBL] [Abstract][Full Text] [Related]
13. Toll-like receptor 4 mediates inflammatory signaling by bacterial lipopolysaccharide in human hepatic stellate cells.
Paik YH; Schwabe RF; Bataller R; Russo MP; Jobin C; Brenner DA
Hepatology; 2003 May; 37(5):1043-55. PubMed ID: 12717385
[TBL] [Abstract][Full Text] [Related]
14. Melatonin modulates TLR4-mediated inflammatory genes through MyD88- and TRIF-dependent signaling pathways in lipopolysaccharide-stimulated RAW264.7 cells.
Xia MZ; Liang YL; Wang H; Chen X; Huang YY; Zhang ZH; Chen YH; Zhang C; Zhao M; Xu DX; Song LH
J Pineal Res; 2012 Nov; 53(4):325-34. PubMed ID: 22537289
[TBL] [Abstract][Full Text] [Related]
15. Poly I:C prevents T cell-mediated hepatitis via an NK-dependent mechanism.
Wang J; Sun R; Wei H; Dong Z; Gao B; Tian Z
J Hepatol; 2006 Mar; 44(3):446-54. PubMed ID: 16310275
[TBL] [Abstract][Full Text] [Related]
16. Selective priming to Toll-like receptor 4 (TLR4), not TLR2, ligands by P. acnes involves up-regulation of MD-2 in mice.
Romics L; Dolganiuc A; Kodys K; Drechsler Y; Oak S; Velayudham A; Mandrekar P; Szabo G
Hepatology; 2004 Sep; 40(3):555-64. PubMed ID: 15349893
[TBL] [Abstract][Full Text] [Related]
17. Dasatinib inhibits the secretion of TNF-alpha following TLR stimulation in vitro and in vivo.
Fraser CK; Lousberg EL; Kumar R; Hughes TP; Diener KR; Hayball JD
Exp Hematol; 2009 Dec; 37(12):1435-44. PubMed ID: 19786067
[TBL] [Abstract][Full Text] [Related]
18. Toll-like receptor 4 mediates the antitumor host response induced by a 55-kilodalton protein isolated from Aeginetia indica L., a parasitic plant.
Okamoto M; Oh-E G; Oshikawa T; Furuichi S; Tano T; Ahmed SU; Akashi S; Miyake K; Takeuchi O; Akira S; Himeno K; Sato M; Ohkubo S
Clin Diagn Lab Immunol; 2004 May; 11(3):483-95. PubMed ID: 15138173
[TBL] [Abstract][Full Text] [Related]
19. Ketamine inhibits tumor necrosis factor-alpha and interleukin-6 gene expressions in lipopolysaccharide-stimulated macrophages through suppression of toll-like receptor 4-mediated c-Jun N-terminal kinase phosphorylation and activator protein-1 activation.
Wu GJ; Chen TL; Ueng YF; Chen RM
Toxicol Appl Pharmacol; 2008 Apr; 228(1):105-13. PubMed ID: 18191973
[TBL] [Abstract][Full Text] [Related]
20. Expression of Toll-like receptor 4 in various organs in rats with D-galactosamine-induced acute hepatic failure.
Kitazawa T; Tsujimoto T; Kawaratani H; Fujimoto M; Fukui H
J Gastroenterol Hepatol; 2008 Aug; 23(8 Pt 2):e494-8. PubMed ID: 18070011
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
